Atlas Trials

Skin Changes in Head and Neck Cancer During Immuno-(Chemo-) And Radiotherapy With Erbitux® (HICARE)

Clinical trial NCT01553032 · COMPLETED

Trial details

NCT number
NCT01553032
Sponsor
University of Heidelberg Medical Center
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Head and Neck Cancer
Start date
2011-06-01
Primary completion
2017-05-01
Enrollment
139

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.